Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma

Shuang Wu; Shihai Liu; Yongxian Cao; Geng Chao; Peng Wang; Huazheng Pan

doi:doi:10.18632/aging.203939

← Back

Research Paper Volume 14, Issue 5 pp 2304—2319

Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma

Figure 2. Overall survival (OS) and disease-free survival (RFS) analysis for ZC3H13 in various human cancers determined by the GEPIA database. The OS and RFS plots of ZC3H13 in BRCA (A, B). The OS and RFS plots of ZC3H13 in KIRC (C, D). The OS and RFS plots of ZC3H13 in LIHC (E, F). The OS and RFS plots of ZC3H13 in LUAD (G, H). The OS and RFS plots of ZC3H13 in STAD (I, J).